Lophius Biosciences Overview
- Founded
- 2002
- Status
- Acquired/Merged
- Employees
- 14
- Latest Deal Type
- M&A
Lophius Biosciences General Information
Description
Developer of immune diagnostic systems designed to transform treatment paradigms and patient management with molecular diagnostics. The company's systems facilitate an efficient stimulation of a broad spectrum of clinically-relevant immune effector cells to accurately measure the cell-mediated immunity, enabling physicians to differentiate between active T-cells versus T-memory cells and identify patients with a contagious active disease and latent infection.
Contact Information
Website
www.lophius.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Other Devices and Supplies
Discovery Tools (Healthcare)
Parent Company
Mikrogen
Primary Office
- Am BioPark 13
- 93053 Regensburg
- Germany
+49 0941 00000000
Lophius Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Merger/Acquisition | 08-Mar-2021 | 0000 | Completed | Generating Revenue | ||
| 11. Later Stage VC | 19-Sep-2019 | 00.000 | 0000 | 000.00 | Completed | Generating Revenue |
| 10. Grant | 31-May-2017 | 00.000 | 000.00 | Completed | Generating Revenue | |
| 9. Later Stage VC | 16-Mar-2017 | 00.000 | 000.00 | 000.00 | Completed | Generating Revenue |
| 8. Later Stage VC | 01-Jul-2016 | 00.000 | 000.00 | 000.00 | Completed | Generating Revenue |
| 7. Grant | 28-Oct-2015 | 000.00 | 00.000 | Completed | Generating Revenue | |
| 6. Later Stage VC | 10-Sep-2015 | 00.000 | Completed | Generating Revenue | ||
| 5. Later Stage VC | 08-May-2014 | 00.000 | 00.000 | 000.00 | Completed | Generating Revenue |
| 4. Later Stage VC | 22-Jan-2013 | $5.22M | Completed | Generating Revenue | ||
| 3. Later Stage VC | 18-Jul-2011 | $2.29M | $5.22M | 00.000 | Completed | Generating Revenue |
Lophius Biosciences Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of immune diagnostic systems designed to transform treatment paradigms and patient management with molecular d
Diagnostic Equipment
Regensburg, Germany
14
As of 2021
0000
000000&0
0000
0000000
a commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu
0000000000 000000000
Regensburg, Germany
00
As of 0000
000.00
0000
0000-00-00
0000000000 0
000.00
00000000
amco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volu
0000 000000000
Berlin, Germany
00
As of 0000
00000
0000000000 0
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialLophius Biosciences Competitors (6)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| numares | Venture Capital-Backed | Regensburg, Germany | 00 | 000.00 | 0000000000 0 | 000.00 |
| 000000000 | Venture Capital-Backed | Berlin, Germany | 00 | 00000 | 0000000000 0 | 00000 |
| 00000000 | Venture Capital-Backed | Heidelberg, Germany | 00 | 000.00 | 0000000000 | 000.00 |
| 000000 00000000000 | Corporation | Cambridge, MA | 000 | 00000 | 000000 - 000 | 00000 |
| 000000000 | Formerly VC-backed | Vancouver, Canada | 000 | 00000 | 000000 - 000 | 00000 |
Lophius Biosciences Executive Team (8)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Bernd Merkl | Chief Executive Officer & Managing Director | ||
| Ludwig Deml Ph.D | Co-Founder & Chief Scientific Officer |
Lophius Biosciences Board Members (8)
| Name | Representing | Role | Since |
|---|---|---|---|
| Manfred Baier Ph.D | Lophius Biosciences | Board Member | 000 0000 |
| Monika Steger | Bayern Kapital | Board Member | 000 0000 |
| Ralf Wagner Ph.D | Self | Chairman | 000 0000 |
| Robert Silverman | Self | Board Member | 000 0000 |
| Stefan Beil Ph.D | Sobera Capital | Board Member | 000 0000 |
Lophius Biosciences Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialLophius Biosciences Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Bayern Kapital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Bundesministerium für Bildung und Forschung | Government | 000 0000 | 000000 0 | ||
| Heidelberg Innovation Fonds Management | Venture Capital | Minority | 000 0000 | 000000 0 | |
| High-Tech Gründerfonds | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Horizon 2020 | Government | 000 0000 | 000000 0 |